148 D.R. CURTIS and G.A.R. JOHNSTON: ..-., ~o 2- ~o 2- Z ~ ~'~ ~o ~,~ z .~ ~,~ o < Z Z ~o~ o ~ < ~,o ~Zz~ ~z Z Z © © 2~ © ;> ~. o r-: er~ "2. ~ o.~.~ ;> o, #" ,,~ ~.~ ,q. ~. o~a~a ;> -#'0o c9 r',l ~ m 0 Z ~ N oG'~, cD ~ ~,.h t¢3 t ~ ~.m. ,d ¢q "R. ,q oq ",O O'~ '-~ o, m ~
<strong>Am<strong>in</strong>o</strong> Acid Transmitters <strong>in</strong> <strong>the</strong> Mammalian Central Nervous System 149 Table 9. Enzyme levels <strong>in</strong> extracts of cat sp<strong>in</strong>al cord and roots (~tmole/hr/g wet tissue) Enzyme Dorsal Dorsal Dorsal Ventral Ventral Ventral Reference roots white grey grey white roots Aspartate 545 2 454 5 412 5 418 2 480 537 GRAHAM and APRISON transam<strong>in</strong>ase (1969) Glutamate 17 149 446 448 139 16 GRAHAM and APRISON dehydrogenase (1969) Glutam<strong>in</strong>e 7 20 67 67 19 4 GRAHAM and APRISON syn<strong>the</strong>tase (I 969) Glutam<strong>in</strong>ase 12 67 397 331 66 13 GRAHAM and APRISON (1969) Glutamate 4 0 13 a 7 0 3 GRAHAM and APR1SON decarboxylase (1969) GABA 1 3 14 13 3 1 GRAHAM and APRISON transam<strong>in</strong>ase (1969) D-<strong>Am<strong>in</strong>o</strong> <strong>acid</strong> 0.8 2.2 2.1 0.4 DE MARCHI and oxidase JOHNSTON (1969) Glyc<strong>in</strong>e 6.6 9.9 9.6 7 JOHNSTON, VITALI transam<strong>in</strong>ase and ALEXANDER (1970) Ser<strong>in</strong>e hydroxy- 2.5 4.3 a 5 2.5 DAVIES and methyltransferase JOHNSTON (1973) a Levels <strong>in</strong> dorsal grey significantly different from those <strong>in</strong> ventral grey. (DAvIDOFF et al., 1967). In <strong>the</strong>se animals, which showed no response to nociceptive cutaneous stimulation <strong>in</strong> <strong>the</strong> affected segments, sp<strong>in</strong>al monosynaptic reflexes were enhanced, polysynaptic reflexes were reduced, and although some evidence has been obta<strong>in</strong>ed for antidromic <strong>in</strong>hibition mediated by Renshaw cells, details have not been published regard<strong>in</strong>g o<strong>the</strong>r types of sp<strong>in</strong>al <strong>in</strong>hibition (MuRAYAMA and SMITH, 1965). In <strong>the</strong> rat; however, h<strong>in</strong>dlimb rigidity produced <strong>in</strong> <strong>the</strong> same fashion is accompanied by reduced responses to pa<strong>in</strong>ful cutaneous stimulation, enhanced monosynaptic and reduced polysynaptic reflexes, and reduction of two types of <strong>in</strong>hibition of ankle extensor motoneurones: short latency ("postsynaptic") <strong>in</strong>hibition by impulses <strong>in</strong> <strong>the</strong> deep peroneal nerve and prolonged (" presynaptic ") <strong>in</strong>hibition by repetitive impulses <strong>in</strong> <strong>the</strong> posterior biceps nerve (MATSUSHITA and SMITH, 1970). There is thus evidence <strong>in</strong> <strong>the</strong>se studies of a loss of both excitatory and <strong>in</strong>hibitory sp<strong>in</strong>al mechanisms associated with <strong>in</strong>terneurones. Useful <strong>in</strong>formation might also. be provided by transection of dorsal roots, although subsequent alterations <strong>in</strong> am<strong>in</strong>o <strong>acid</strong> levels and associated enzymes may be complicated by disturbances of <strong>the</strong> blood supply (Rat: SUGAR and GER- ARD, 1940. Cat: CHAMBERS, ELDRED, and EGGETT, 1972) <strong>in</strong> addition to loss of primary afferent fibres. With both aortic occlusion and de-afferentation, histological control and unchanged levels of some metabolites are required to exclude "non-specific" loses of am<strong>in</strong>o <strong>acid</strong>s produced by <strong>in</strong>farction, oedema, gliosis or cavity formation (see DAVIDOEE et al., 1967).